Search

everythinglearnresearchcommunity

for

Search:↓

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

Female hair loss is influenced by genetics and hormones, often starting in middle age or after hormonal changes.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

A postmenopausal woman with hair loss and hirsutism improved after surgery to remove an ovarian tumor.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Hormone replacement therapy can improve skin aging in postmenopausal women.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.